Cilazapril

ATC C09AA08 · 3 markets · 62 records

Cilazapril 3 markets · 62 records Forms

GB 20 records · 4 strengths

5 mgtabletVascace 1mg tablets+1__no_trade__ also in CA
2.5 mgtabletVascace 1mg tablets also in CA
1 mgtabletVascace 1mg tablets also in CA

Records without a stated strength · 1 Vascace 500microgram tablets

CA 8 records · 3 strengths

5 mgtabletAPO-CILAZAPRIL+4APO-CILAZAPRIL/HCTZ、INHIBACE 1MG、INHIBACE PLUS、MYLAN-CILAZAPRIL also in GB
2.5 mgtabletAPO-CILAZAPRIL+1MYLAN-CILAZAPRIL also in GB
1 mgtabletMYLAN-CILAZAPRIL also in GB

ES 1 records · 1 strengths

12.5 mgtabletINHIBACE PLUS mg/12,5mg

Side-by-side table

Strength / form / release	GB	CA	ES
5 mg tablet	No trade name Vascace 1mg tablets	APO-CILAZAPRIL APO-CILAZAPRIL/HCTZ INHIBACE 1MG +2 INHIBACE PLUS MYLAN-CILAZAPRIL	not recorded
2.5 mg tablet	Vascace 1mg tablets	APO-CILAZAPRIL MYLAN-CILAZAPRIL	not recorded
1 mg tablet	Vascace 1mg tablets	MYLAN-CILAZAPRIL	not recorded
12.5 mg tablet	not recorded	not recorded	INHIBACE PLUS mg/12,5mg
not disclosed tablet	Vascace 500microgram tablets	not recorded	not recorded

Scroll horizontally for more markets →

Each country column shows the locally registered trade names — not translations.

“not disclosed” means the source does not publish the strength — it does not mean the product has none.

Back to the list

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.